What is the diagnosis when an echocardiogram shows both mitral and tricuspid regurgitation?

Diagnosis: Multiple Valvular Heart Disease (MVD) with Combined Mitral and Tricuspid Regurgitation

When an echocardiogram shows both mitral and tricuspid regurgitation, the diagnosis is multiple valvular heart disease (MVD), and you must determine whether each valve lesion is primary (organic) or secondary (functional) to guide management. 1

Understanding the Mechanism

The key diagnostic challenge is distinguishing the underlying etiology and mechanism:

Tricuspid Regurgitation in Context of Mitral Disease

In most cases, TR accompanying mitral regurgitation is secondary (functional) rather than primary organic disease 2. The TR develops from:

• Right ventricular and tricuspid annular dilation secondary to left-sided valve disease
• Pulmonary hypertension from chronic mitral disease
• Tricuspid annular dilatation (≥3.5 cm is significant) 3
• Leaflet tethering from RV remodeling
• Chronic atrial fibrillation 3

Primary vs Secondary Disease

You must differentiate:

• Rheumatic heart disease: Can affect both valves simultaneously with characteristic leaflet thickening, calcification, and restricted motion 4
• Functional TR: Most common - develops from hemodynamic consequences of mitral disease 2, 3
• Ischemic disease: Both valves may be affected by coronary disease causing ventricular remodeling 5
• Degenerative disease: Less commonly causes combined pathology 3

Critical Diagnostic Steps

Echocardiographic Assessment Required

Use comprehensive 2D/3D transthoracic echocardiography as first-line imaging 1, 2:

1. Assess valve morphology: Look for rheumatic changes (thickening, calcification, restricted motion) vs normal leaflets suggesting functional disease

2. Quantify regurgitation severity for each valve using:

   • Effective regurgitant orifice area (EROA)
   • Regurgitant volume
   • Vena contracta width
   • Color Doppler jet characteristics

3. Measure tricuspid annular diameter: ≥3.5 cm indicates significant dilation 3

4. Evaluate RV size and function: RV dilation and dysfunction indicate advanced disease

5. Assess pulmonary artery pressure: Elevated pressures suggest chronic left-sided disease

6. Measure right atrial size: Enlargement predicts worse outcomes 6

Advanced Imaging When Needed

Consider cardiac MRI when echocardiography is technically limited or for complex cases 1. CMR provides:

• Gold standard RV size and function quantification
• Accurate regurgitant volume measurements
• Assessment of myocardial fibrosis

Prognostic Implications

The combination of mitral and tricuspid regurgitation carries significantly worse prognosis than either lesion alone 7, 8:

• Even mild MR with mild TR reduces survival compared to no valvular disease 8
• Combined moderate/severe MR and TR has particularly poor outcomes with only 21% event-free survival at 24 months in atrial fibrillation patients 7
• Moderate/severe TR independently predicts mortality even after adjusting for other factors 9

Common Pitfalls to Avoid

1. Don't assume TR will resolve after treating mitral disease alone: TR frequently persists or progresses after isolated mitral surgery 3, 5

   • Without tricuspid repair: 31% with no preoperative TR develop moderate+ TR by 5 years 5
   • With moderate preoperative TR: 62% have moderate+ TR at 5 years without tricuspid intervention 5

2. Don't delay intervention until severe RV dysfunction develops: Isolated tricuspid surgery after RV dysfunction has poor outcomes 3

3. Don't rely solely on TR severity grading: Tricuspid annular diameter (≥3.5 cm) is the best criterion for determining need for concomitant tricuspid repair 3

4. Don't overlook right-sided ischemic disease: TR may be a direct consequence of right coronary disease, not just secondary to left-sided pathology 5

Clinical Context Matters

The specific diagnosis depends on additional findings:

• Longstanding atrial fibrillation: Increases likelihood of functional TR 7
• History of rheumatic fever: Suggests rheumatic MVD 4
• Coronary artery disease: Consider ischemic mechanism 5
• Symptoms >6 years: Higher prevalence of significant TR 10
• Elevated right heart pressures: Indicates hemodynamically significant disease 10